Urinalysis Market By Product Type 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Urinalysis Market
Urinalysis Market: By Product Type (Consumables, Biochemical Urine Analyzers, Others); By Test Type (Biochemical, Microscopic, Others); By Application (UTI, Diabetes, Others); By End-User (Hospitals, Clinical Laboratories, Others) & By Region-Forecast (2016-2022)
Report Code : HCR 0704
Updated Date: 10 March, 2016  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Urinalysis Market – Overview
2. Executive Summary 
3. Urinalysis Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Urinalysis Market– Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Growing prevalence of kidney diseases and urinary tract infections
   4.2. Restraints
      4.2.1. Higher cost of research and development 
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Urinalysis Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Urinalysis Market, By Product Type
   6.1. Consumables 
   6.2. Biochemical Urine Analyzers
   6.3. Automated Urine Sediment Analyzers
   6.4. Point-Of-Care Devices 
7. Urinalysis Market, By Test Type
   7.1. Biochemical Urinalysis 
   7.2. Microscopic  Urinalysis
   7.3. Flow Cytometric Urinalysis 
8. Urinalysis Market, By Application 
   8.1. Urinary Tract Infection
   8.2. Diabetes
   8.3. Kidney Diseases
   8.4. Hypertension
   8.5. Liver Diseases
   8.6. Pregnancy
9. Urinalysis Market, By End-User 
   9.1. Hospitals
   9.2. Clinical Laboratories
   9.3. Home Healthcare
   9.4. Research
   9.5. Academics
10. Urinalysis Market, By Geography
   10.1. Europe
      10.1.1. Germany
      10.1.2. France
      10.1.3. Italy
      10.1.4. Spain
      10.1.5. Russia
      10.1.6. U.K.
      10.1.7. Rest of Europe
   10.2. Asia Pacific
      10.2.1. China
      10.2.2. India
      10.2.3. Japan
      10.2.4. South Korea
      10.2.5. Rest of Asia-Pacific
   10.3. North America 
      10.3.1. U.S.
      10.3.2. Canada
      10.3.3. Mexico
   10.4. Rest of the World (RoW)
      10.4.1. Brazil
      10.4.2. Rest of RoW
11. Urinalysis Market – Entropy
   11.1. Expansion
   11.2. Technological Developments
   11.3. Merger & Acquisitions, and Joint Ventures
   11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. Mindray Medical International Limited 
   12.2. Urit Medical Electronic Group Co., Ltd.
   12.3. Siemens Healthcare (Subsidiary of Siemens AG) 
   12.4. Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.) 
   12.5. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)  
   12.6. Sysmex Corporation 
   12.7. Arkray, Inc. 
   12.8. Acon Laboratories, Inc. 
   12.9. Bio-Rad Laboratories, Inc. 
   12.10. Elektronika Kft. 
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Urinalysis is a test of urine to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease and diabetes. Globally, development of efficient and advanced technology, rise in the awareness among people regarding urinary tract infections, increasing government initiative across the globe, growing prevalence of kidney diseases and urinary tract infections, rising healthcare expenditure are the prime growth drivers of the urinalysis market. In addition, emergence of portable and battery-operated urinalysis devices, and increase in adoption of urinalysis in emerging economies such as China, India and others, will create new opportunities for the urinalysis market. However, higher cost of the research and development, and stringent government regulations are the key restraints for the urinalysis market.

 Urinalysis Market

Geographically, North America dominated the urinalysis market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing aging population, rise in consumer awareness, increasing prevalence of diseases, such as diabetes, kidney diseases, and Urinary Tract Infections (UTI), favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the end-users, clinical laboratories segment has the highest market share in the urinalysis market due to higher procedure volumes.

This report identifies the urinalysis market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the urinalysis market.

This report segments the urinalysis market on the basis of product type, test type, application, end-user, and regional market as follows:
  • Urinalysis Market, By Product Type: Consumables, Biochemical Urine Analyzers, Automated Urine Sediment Analyzers, and Point-Of-Care Devices
  • Urinalysis Market, By Test Type: Biochemical Urinalysis, Microscopic  Urinalysis, and Flow Cytometric Urinalysis
  • The report has focused study on urinalysis market by basis of application such as: Urinary Tract Infection, Diabetes, Kidney Diseases, Hypertension, Liver Diseases, and Pregnancy
  • The report has focused study on urinalysis market by basis of end-user such as: Hospitals, Clinical Laboratories, Home Healthcare, Research, and Academics
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the urinalysis market. 

Sample Companies Profiled in this Report are:
  • Mindray Medical International Limited 
  • Urit Medical Electronic Group Co., Ltd.
  • Siemens Healthcare (Subsidiary of Siemens AG) 
  • Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.) 
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • 10+
List of Tables:

Table 1: Global Urinalysis Market Revenue, By Product Type, 2016-2022 ($Million)
Table 2: Global Urinalysis Market Revenue, By Test Type, 2016-2022 ($Million)
Table 3: Global Urinalysis Market Revenue, By Application, 2016-2022 ($Million)
Table 4: Europe Urinalysis Market Revenue, By Product Type, 2016-2022 ($Million)
Table 5: Europe Urinalysis Market Revenue, By Test Type, 2016-2022 ($Million)
Table 6: Europe Urinalysis Market Revenue, By Application, 2016-2022 ($Million)
Table 7: Europe Urinalysis Market Revenue, By End User, 2016-2022 ($Million)
Table 8: Germany: GDP – Composition of 2016, By End Use
Table 9: France: GDP – Composition of 2016, By End Use
Table 10: Italy: GDP – Composition of 2016, By End Use
Table 11: GDP – Composition of 2016, By End Use
Table 12: U.K.: GDP – Composition of 2016, By End Use
Table 13: Asia-Pacific Urinalysis Market Revenue, By Product Type, 2016-2022 ($Million)
Table 14: Asia-Pacific Urinalysis Market Revenue, By Test Type, 2016-2022 ($Million)
Table 15: Asia-Pacific Urinalysis Market Revenue, By Application, 2016-2022 ($Million)
Table 16: Asia-Pacific Urinalysis Market Revenue, By End - User, 2016-2022 ($Million)
Table 17: China: GDP – Composition of 2015, By End Use
Table 18: India: GDP – Composition of 2016, By End Use
Table 19: Japan: GDP – Composition of 2016, By End Use
Table 20: Korea: GDP – Composition of 2016, By End Use
Table 21: North America: Urinalysis Market Revenue, By Product Type, 2016-2022 ($Million)
Table 22: North America: Urinalysis Market Revenue, By Test Type, 2016-2022 ($Million)
Table 23: North America: Urinalysis Market Revenue, By Application, 2016-2022 ($Million)
Table 24: North Americas: Urinalysis Market Revenue, By End-User, 2015-2023 ($Million)
Table 25: U.S.: GDP – Composition of 2015, By End Use
Table 26: Canada: GDP – Composition of 2015, By End Use
Table 27: Mexico: GDP – Composition of 2015, By End Use
Table 28: RoW: Urinalysis Market Revenue, By Product Type, 2016-2022 ($Million)
Table 29: RoW: Urinalysis Market Revenue, By Test Type, 2016-2022 ($Million)
Table 30: RoW: Urinalysis Market Revenue, By Application, 2016-2022 ($Million)
Table 31: RoW: Urinalysis Market Revenue, By End-User, 2016-2022 ($Million)


List of Figures:

Figure 1: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 2: Urinalysis Market Revenue Share, By Product Type, 2016 (%)
Figure 3: Urinalysis Market Revenue, By Test Type, 2016, 2022 ($Million)
Figure 4: Urinalysis Market Revenue Share, By Application, 2016 (%)
Figure 5: Urinalysis Market Revenue Share, By End-User, 2016 (%)
Figure 6: Urinalysis Market Revenue, By Geography, 2016, 2022 ($Million)
Figure 7: Global Urinalysis Market Revenue Share, By Company, 2016 (%)
Figure 8: Urinalysis Patents, By Year, 2013-2017
Figure 9: Siemens AG
Figure 10: Sysmex Corporation
Figure 11: F. Hoffmann-La Roche
Figure 12: Danaher Corporation
Figure 13: EPS, By Company, 2014-2016 ($)
Figure 14: Urinalysis Value Chain
Figure 15: Urinalysis Market Life Cycle Analysis
Figure 16: Consumables: Urinalysis Market Revenue, 2016-2022 ($Million):
Figure 17: Biochemical Urine Analyzers: Urinalysis Market Revenue, 2016-2022 ($Million):
Figure 18: Automated Urine Sediment Analyzers: Urinalysis Market Revenue, 2016-2022 ($Million):
Figure 19: Point of Care Devices: Urinalysis Market Revenue, 2016-2022 ($Million):
Figure 20: Biochemical Urinalysis: Urinalysis Market Revenue, 2016-2022 ($Million):
Figure 21: Microscopic Urinalysis: Urinalysis Market Revenue, 2016-2022 ($Million):
Figure 22: Flow Cytometric Urinalysis: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 23: Global Urinalysis Market - By Application
Figure 24: Urinary Tract Infection: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 25: Diabetes: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 26: People Diagnosed with Diabetes, U.S., 2010-2015 (M)
Figure 27: Kidney Diseases: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 28: Hypertension: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 29: Liver Diseases: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 30: Pregnancy: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 31: Urinalysis Market, By End-User
Figure 32: Hospitals & Clinics: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 33: Clinical laboratories: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 34: Home healthcare: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 35: Research and Academics: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 36: Germany: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 37: Germany: GDP – Composition of 2016, By Sector of Origin
Figure 38: Germany: Export and Import Value, 2013-2016 ($Billion)
Figure 39: France: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 40: France: GDP – Composition of 2016, By Sector of Origin
Figure 41: France: Export and Import Value, 2013-2016 ($Billion)
Figure 42: Italy: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 43: Italy: GDP – Composition of 2016, By Sector of Origin
Figure 44: Italy: Export and Import Value, 2013-2016 ($Billion)
Figure 45: Russia: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 46: GDP – Composition of 2016, By Sector of Origin
Figure 47: The Russia: Export and Import Value, 2013-2016($Billion)
Figure 48: U.K.: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 49: U.K.: GDP – Composition of 2016, By Sector of Origin
Figure 50: U.K.: Export and Import Value, 2013-2016 ($Billion)
Figure 51: Germany Beer Consumption, 2010 – 2016 (In 1,000 Hl)
Figure 52: France Population ages 65 and above, 2012-2016 (% of total)
Figure 53: Italy Health Expenditure Per Capita, 2009-2014 ($)
Figure 54: Spain: Number of Deaths from Diabetes in Spain, 2016, By Gender and Age
Figure 55: U.K.: Number of Maternal Deliveries in National Health Service (NHS) Hospitals, 2010 - 2016
Figure 56: Russia: Health Expenditure Per Capita, 2009-2014 ($)
Figure 57: Germany: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 58: France: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 59: Italy: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 60: Spain: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 61: Russia: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 62: U.K.: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 63: Rest of Europe: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 64: China: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 65: China: GDP – Composition of 2016, By Sector of Origin
Figure 66: China: Export and Import Value, 2013-2016 ($Billion)
Figure 67: India: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 68: India: GDP – Composition of 2016, By Sector of Origin
Figure 69: India: Export and Import Value, 2013-2016 ($Billion)
Figure 70: Japan: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 71: Japan: GDP – Composition of 2016, By Sector of Origin
Figure 72: Japan: Export and Import Value, 2013-2016 ($Billion)
Figure 73: Korea: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 74: Korea: GDP – Composition of 2016, By Sector of Origin
Figure 75: Korea: Export and Import Value, 2013-2016 ($Billion)
Figure 76: Diabetes Health Expenditure, 2017 ($Billion)
Figure 77: Consumption of Wine Among Urban Consumers, 2017, By Country of Origin
Figure 78: Japan Health Expenditure Per Capita, 2009-2014 ($)
Figure 79: South Korea Population Ages 65 and above, 2010-2016 (% of Total)
Figure 80: Rest of Asia-Pacific: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 81: U.S.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 82: U.S.: GDP – Composition of 2015, By Sector of Origin
Figure 83: U.S.: Export and Import Value, 2012-2015 ($Trillion)
Figure 84: Canada: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 85: Canada: GDP – Composition of 2015, By Sector of Origin
Figure 86: Canada: Export and Import Value, 2012-2015 ($Billion)
Figure 87: Mexico: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 88: Mexico: GDP – Composition of 2015, By Sector of Origin
Figure 89: Mexico: Export and Import Value, 2012-2015 ($Billion)
Figure 90: U.S.: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 91: Canada: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 92: Mexico: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 93: North America: Urinalysis Market Growth, By Country 2017-2022 (%)
Figure 94: South America: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 95: Middle East: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 96: Africa: Urinalysis Market Revenue, 2016-2022 ($Million)
Figure 97: RoW: Urinalysis Market Growth, By Region, 2017-2022 (%)
Figure 98: National Prevalence of Diabetes in Middle East Countries (%)
Figure 99: Siemens AG, Revenue, 2015-16 ($Billion)
Figure 100: Siemens AG Market Revenue Share, By Segment, 2016(%)
Figure 101: Siemens AG Market Revenue Share, By Geography, 2016 (%)
Figure 102: F-Hoffmann-La Roche Ltd., Revenue, 2015-16 ($Billion)
Figure 103: F-Hoffmann-La Roche Ltd. Market Share, By Segment 2016 (%)
Figure 104: Danaher Corporation Market Share, By Segment, 2016 (%)
Figure 105: Danaher Corporation Sales, 2014-16 ($Billion)
Figure 106: Sysmex Corporation, Revenue, 2014-2017 ($Billion)
Figure 107: Sysmex Corporation, Market Share, By Geography, 2017 (%)
Figure 108: Bio-Rad Laboratories, Inc., Revenue, 2013-2016 ($Billion)
Figure 109: Bio-Rad Laboratories, Inc., Revenue Share, By Business Segment, 2016 (%)
Figure 110: Bio-Rad Laboratories, Inc., Revenue Share, By Geography, 2016 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll